SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 138 filers reported holding SAGE THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 1.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $38,064,000 | +190.3% | 440,000 | +198.7% | 0.41% | -18.2% |
| Q4 2018 | $13,110,000 | +3582.6% | 147,315 | -65.7% | 0.50% | +7028.6% |
| Q3 2017 | $356,000 | -98.4% | 430,000 | +56.4% | 0.01% | -99.4% |
| Q2 2017 | $21,901,000 | +1014.0% | 275,000 | +37.5% | 1.10% | +883.9% |
| Q1 2017 | $1,966,000 | +68.6% | 200,000 | +900.0% | 0.11% | +30.2% |
| Q4 2015 | $1,166,000 | -31.2% | 20,000 | -50.0% | 0.09% | +26.5% |
| Q3 2015 | $1,694,000 | +16.0% | 40,000 | +100.0% | 0.07% | -22.7% |
| Q2 2015 | $1,460,000 | -58.8% | 20,000 | -71.6% | 0.09% | -68.0% |
| Q1 2015 | $3,540,000 | +37.2% | 70,484 | 0.0% | 0.28% | +27.3% |
| Q4 2014 | $2,580,000 | -60.7% | 70,484 | -66.2% | 0.22% | -69.4% |
| Q3 2014 | $6,573,000 | – | 208,676 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |